抗CTLA-4抗体可能对具有大型瘤的大型非小细胞肺癌有效

相关实验视频

Updated: Jul 17, 2025

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

10.6K

Hiroshi Saijo1, Yoshihiko Hirohashi2, Osamu Honjo3

  • 1Department of Respiratory Medicine, Sapporo Minami-Sanjo Hospital, Sapporo, Japan; h_saijo@h-keiaikai.or.jp.

Anticancer research
|August 30, 2023
PubMed
概括

免疫检查点抑制剂 (ICI) 在大型非小细胞肺癌 (NSCLC) 中由于调控性T细胞透而显示出降低的疗效. 基于抗CTLA-4抗体的免疫疗法可以为大型NSCLC提供改善的结果.

关键词:
在NSCLCLC中,我们可以看到.在Treg细胞中.对抗CTLA-4抗体的抗体生物标志物生物标志物瘤的大小 瘤大小

更多相关视频

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients07:43

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on: September 25, 2018

10.6K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.5K

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
555
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K